Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Sector news Pharmaceuticals - NEC
03:19pBarclays Poaches Senior Health-Care Banker From Deutsche Bank
DJ
02:37pNovartis, MorphoSys and Galapagos Shares Rise on News of Deal
DJ
11:55aBarclays appoints Campili as vice chairman for healthcare banking
RE
08:48aNOVARTIS : Freezes Its Drug Prices -- WSJ
DJ
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/18Novartis hints at 2018 outlook hike despite drug price freeze
RE
07/18Novartis hints at 2018 outlook hike despite drug price freeze
RE
07/18NOVARTIS : FDA Expands Approval of Novartis Breast Cancer Drug
DJ
07/18ABBOTT LABORATORIES : on Track for All-Time High After 2Q Earnings -- Data Talk
DJ
07/18NOVARTIS : to Refrain From Rising U.S. Drug Prices -- 3rd Update
DJ
07/18NOVARTIS : to Refrain From Raising U.S. Drug Prices -- 2nd Update
DJ
07/18ABBOTT LABORATORIES : Sales Rise, Lifts Full-Year Outlook -- Earnings Review
DJ
07/18NOVARTIS : to Refrain From Raising U.S. Drug Prices -- Update
DJ
07/18Pfizer, Lilly See Positive Top-Line Results From Phase 3 Trial of Tanezumab
DJ
07/18ASTRAZENECA : Increases Drug Stockpile in Preparation for Hard Brexit
DJ
07/18ASTRAZENECA : to stockpile drugs as Brexit 'safety net'
RE
07/18NOVARTIS : Backs 2018 Outlook, Says Cohen Affair Is 'Closed' -- Update
DJ
07/18JOHNSON & JOHNSON : J&J's Pharma Business Fuels Sales Growth -- WSJ
DJ
07/18NOVARTIS : Backs 2018 Outlook After Sales Grow
DJ
07/17JOHNSON & JOHNSON : J&J beats quarterly expectations on drug sales surge, shares..
RE
07/17JOHNSON & JOHNSON : Pharma Business Fuels Sales Growth -- Update
DJ
07/17Johnson & Johnson on Track for Largest Intraday Percent Increase Since Jan 20..
DJ
07/17ABBVIE : Signs Humira Patent License with Mylan
DJ
07/17JOHNSON & JOHNSON : Pharmaceuticals Business Delivers, but Company Lowers Sales ..
DJ
07/17Investor 2Q Net Profit Rises 34%
DJ
07/17SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/16Startup Producing Cell-Grown Meat Raises New Funding
DJ
07/16J&J'S JANSSEN : Credence Trial of Invokana Being Stopped Early for Positive Effi..
DJ
07/16ASTRAZENECA : Swedish Business Appoints New CEO
DJ
07/16Indivior's shares soar 33 percent after U.S. court blocks sale of rival gener..
RE
07/16SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/14INDIVIOR : wins preliminary injunction against generic rival
RE
07/13TEVA PHARMACEUTICAL INDUSTRIES : FDA Recalls Several Medicines That Contain Vals..
DJ
07/13NOVARTIS : Played Down Ties to Trump Lawyer Michael Cohen, Report Says
DJ
07/13JOHNSON & JOHNSON : J&J vows to overturn $4.7 billion talc verdict but experts s..
RE
07/13NOVARTIS : disputes U.S. senators' report on Cohen contract
RE
07/13Vattenfall Signs Wind-Energy Deal With Novo Nordisk, Novozymes
DJ
07/13JOHNSON & JOHNSON : J&J Is Hit by $4.7 Billion Verdict -- WSJ
DJ
07/13JOHNSON & JOHNSON : Jury orders J&J to pay $4.7 billion in Missouri asbestos can..
RE
07/13JOHNSON & JOHNSON : Jury orders J&J to pay $4.7 billion in Missouri asbestos can..
RE
07/12JOHNSON & JOHNSON : J&J Hit With $4.7 Billion Jury Verdict in Baby Powder Suit -..
DJ
07/12JOHNSON & JOHNSON : J&J Hit With $550 Million Jury Verdict in Baby Powder Suit
DJ
07/12NOVARTIS : Shares Lifted by Prospect of Gilenya Exclusivity in US -- Update
DJ
07/12GLAXOSMITHKLINE : Sells Tapinarof Rights for Up to GBP250 Million
DJ
07/12Novartis Becomes Latest Player to Exit Antibiotic, Antiviral Research
DJ
07/12ABBOTT LABORATORIES : Labs Gets FDA Approval for MitraClip for Leaky Heart Valve..
DJ
07/12Lanxess water treatment unit attracts interest - sources
RE
07/12South Korea regulator says Samsung BioLogics violated accounting rules
RE
07/12Exclusive - With U.S. trade under a cloud, China opens to Indian pharma
RE
07/12PFIZER : Plans To Shuffle Its Divisions -- WSJ
DJ
1  2  3  4  5  6  7  8  9  10Next
Financials (CHF)
Sales 2018 55 605 M
EBIT 2018 18 610 M
Net income 2018 11 909 M
Debt 2018 4 021 M
Yield 2018 3,67%
P/E ratio 2018 16,45
P/E ratio 2019 15,98
EV / Sales 2018 3,69x
EV / Sales 2019 3,54x
Capitalization 201 B
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-4.77%200 995
JOHNSON & JOHNSON-7.59%346 292
PFIZER3.95%220 236
NOVARTIS-2.11%200 139
MERCK AND COMPANY11.85%168 225
AMGEN10.87%128 318
ABBOTT LABORATORIES10.04%110 100
SANOFI0.92%104 422
GLAXOSMITHKLINE18.25%101 396
BAYER-9.17%101 370
ELI LILLY AND COMPANY6.05%97 222
NOVO NORDISK A/S-3.87%95 160
ASTRAZENECA9.47%93 044
BRISTOL-MYERS SQUIBB COMPANY-7.59%92 564
CELGENE CORPORATION-17.80%62 226
ALLERGAN PLC7.38%59 560
SHIRE12.92%52 831
JIANGSU HENGRUI MEDICINE CO LTD39.65%39 919
TAKEDA PHARMACEUTICAL CO LTD-27.31%33 424
ASTELLAS PHARMA INC25.21%31 855
DAIICHI SANKYO COMPANY, LIMITED57.14%28 710